Andrea Waldman, MD
Dermatology · Lexington, KYNPI 1134461460
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $27,722 of the $33,385 with a category attached, or 83.0%. Sanofi accounts for 92.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $32,003 and has fallen 97.4% since, to $825 in 2025. Among dermatology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $470.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$31K
- Regeneron Healthcare Solutions, Inc.$1K
- AbbVie$576
- Pfizer$159
- Biofrontera Inc.$125
- Botanix SB Inc$113
- plus $255 from 7 others
What the payments were for
- Speaking & faculty fees$27,72283%
- Travel & lodging$2,7108%
- Food & beverage$2,7818%
- Education$1711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 20 | $30,882 |
| Regeneron Healthcare Solutions, Inc. | 16 | $1,275 |
| AbbVie | 16 | $576 |
| Pfizer | 6 | $159 |
| Biofrontera Inc. | 1 | $125 |
| Botanix SB Inc | 1 | $113 |
| Johnson & Johnson | 2 | $100 |
| Sun Pharmaceutical Industries Inc. | 2 | $39 |
| Incyte Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $31 |
| Amgen | 1 | $17 |
| Viz.ai, Inc. | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$31,315
- AMELUZ$125
- BF-RhodoLED$125
- XEPI$125
- SOFDRA$113
How this compares
$33,385 in reported general payments places this provider in the 90th percentile of 128 dermatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 31 | $225,533 |
| Cosentyx Unoready PenSecukinumab | 23 | $203,142 |
| Dupixent PenDupilumab | 36 | $125,418 |
| AdbryTralokinumab-Ldrm | 11 | $81,179 |
| Dupixent SyringeDupilumab | 16 | $59,473 |
| Tacrolimus | 20 | $2,735 |
| Clobetasol Propionate | 49 | $2,088 |
| Desonide | 41 | $1,603 |
| Mometasone Furoate | 113 | $1,519 |
| Fluocinonide | 35 | $1,424 |
| Fluticasone Propionate | 31 | $1,340 |
| Fluorouracil | 14 | $1,239 |
| Clindamycin Phosphate | 33 | $1,235 |
| Ketoconazole | 58 | $790 |
| Metronidazole | 12 | $469 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lexington
- James WhartonLexington$1.2M
- Dana BlackLexington$16K
- Jonathan KeelingLexington$13K
- Gerald ElliottLexington$12K
- Tandy RepassLexington$9K
- Tessa MullinsLexington$8K
- Joseph BarkLexington$8K
- Erika MusicLexington$7K
- Donna RothLexington$5K
- James LagrewLexington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.